Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson’s Disease
Abstract Cannabis products that contain the tetrahydrocannabinol (THC) cannabinoid are emerging as promising therapeutic agents for the treatment of medical…
pharmacogenomics
Pharmacogenetic-guided cannabis usage in the community pharmacy: evaluation of a pilot program
Abstract Background: Pharmacists possess a skillset suited to provide evidence-based guidance to current and potential users of cannabis. Clinical pharmacogenomics…
Cannabinoids as an Alternative Option for Conventional Analgesics in Cancer Pain Management: A Pharmacogenomics Perspective
Abstract The global cancer burden is significantly increasing at an alarming rate affecting patients, relatives, communities, and health-care system. Cancer…
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Abstract Background: Medicinal cannabis has received increased research attention over recent years due to loosening global regulatory changes. Medicinal cannabis…
Pharmacogenomics of GPCR Drug Targets
Abstract Natural genetic variation in the human genome is a cause of individual differences in responses to medications and is…